Skip to main content
Clinical Trials/CTRI/2026/01/101102
CTRI/2026/01/101102Not yet recruitingNot Applicable

COMPARATIVE EVALUATION OF THE EFFICACY OF TERMINALIA ARJUNA AND TETRACYCLINE DELIVERED LOCALLY AS AN ADJUNCT TO SCALING AND ROOT PLANING A CLINICOBIOCHEMICAL TRIAL

Dr Pooja Yadav self funded1 site in 1 country38 target enrollmentStarted: February 5, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
38
Locations
1
Primary Endpoint
The present study expects more reduction in inflammation on

Study Overview

Brief Summary

Periodontitis is a chronic inflammatory disease of the periodontium caused by oral microbiota that destroy the periodontium to cause a possible tooth loss. The subgingival microbiota and immune inflammatory response of the host is responsible for triggering inflammation in periodontitis. The conventional treatment method, scaling and root planing remains primary non-surgical management of chronic periodontitis. Incorporation of systemic antimicrobial agents as an adjunct to SRP can provide improved outcomes than SRP alone. The use of locally delivered antimicrobials have various advantages over systemic administration. Tetracycline has been used to treat periodontal diseases due to its unique ability to reduce degradation of collagenous matrix by inhibiting the Matrix Metalloproteinases (MMPs). Many, studies have supported that novel drugs derived from herbs and certain plant extract improve periodontal health. Terminalia arjuna is one such plant. The bark extract of Terminalia arjuna shows antibacterial, anti-inflammatory and antioxidative activity even at low concentration.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
Double

Eligibility Criteria

Ages
15.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Age group- 18-50 years.
  • Patient with moderate chronic periodontitis.
  • Probing pocket depth 4-5 mm.
  • Systemically healthy patients.

Exclusion Criteria

  • Pregnant or lactating women.
  • Smokers, Alcoholics Patients who had undergone periodontal therapy in last 6 months.

Outcomes

Primary Outcomes

The present study expects more reduction in inflammation on

Time Frame: Baseline,15 days,30 days

sites treated with T. arjuna gel as compared to tetracycline gel when locally delivered

Time Frame: Baseline,15 days,30 days

as an adjunct to SRP in chronic periodontitis patients.

Time Frame: Baseline,15 days,30 days

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Dr Pooja Yadav self funded
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Pooja Yadav

Faculty Of Dental Sciences, Uttar Predesh University of medical sciences

Study Sites (1)

Loading locations...

Similar Trials